Author | Michael Wyand PhD DVM

Articles

Winning Buy-In On a Biosimilar

December 18, 2014

(ACR14) (VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.